Skip to main content

Indian Scientists Decode Genome Of Indian Cobra

Indian Scientists Decode Genome Of Indian Cobra

Written on 01/07/2020
Prathibha HC


Indian Cobra Genome Sequenced – Can Aid In Developing New Antivenom
A team of Indian scientists and their collaborators abroad have successfully sequenced the genome of the highly poisonous Indian Cobra, in a step taken to reduce the disability and mortality caused by snake bites.
Among the most venomous four snakes in India, which are called collectively as the infamous “big four”, the Indian cobra is the most venomous Indian snake to be genetically mapped. In India, everywhere, nearly 46,000 deaths occur due to snakebites from the four venomous snakes, the Indian cobra, saw-scaled viper, Russell’s viper, and common krait. Around 5.4 million snake bites occur every year worldwide, with 2.8 million of them in India. Globally, they are responsible for 4,00,000 disabilities, of which from India there are around 1,38,000 disabilities.
The President of the Chennai-based SciGenome Research Foundation (SGRF), Sekar Seshagiri and the scientists led by him have assembled the most contiguous genome of the cobra, using a mix of cutting-edge genomic technologies. Experts say that this will help in developing more efficient antibodies.
Scientists found in the present study that there are 19 toxin genes primarily expressed in the venom glands of the Indian cobra. Seshagiri said ” For treating Indian cobra bites, using synthetic human antibodies to target these toxins should lead to a safe and effective antivenom. We will be able to generate antibodies (antivenom) to the other three venomous snakes and develop an anti-venom quickly if we get one good antivenom against the Indian cobra and genome sequences from the other three.
Researchers from US firm Genentech, MedGonome Labs and SGRF’s AgriGenome Labs, Wayanad Wildlife Sanctuary in Kerala and their peers from many universities in the US and Singapore participated in the study, along with Seshagiri’s team.
Outdated procedure
Antivenom that is currently in use is based on a process developed over 100 years ago and is produced by immunizing horses with extracted snake venom. This process suffers from a lack of consistency leading to serious side-effects and varying efficacy and ent also is a laborious process.
An author of the study, R Manjunatha Kini, Professor, National University of Singapore (NUS), Singapore said ” It is high time that we develop antivenom leveraging modern technologies like synthetic antibody development technologies, recombinant protein expression, and genomics. We have the blueprint needed to this from the Indian cobra genome and the catalog of target toxins. Venom also serves as a significant source of drug-like molecules. The genome of Indian cobra is no exception and it codes for toxin molecules that prevent blood clotting, reduce blood pressure and block pain.
Universal antivenom
The Chief Operating Officer of AgriGenome Labs, George Thomas said “The Indian cobra is the first snake to be sequenced among the ‘big four’ deadly snakes. This can effectively change the way antivenom is developed and is a major step towards understanding its venom components.”
Using this genomic blueprint for venom toxins to make recombinant proteins, to generate neutralizing antibodies and test them in the clinic would be the next step, said the scientists. Eventually, a universal antivenom can be developed by further sequencing other snake genomes and the information on additional toxins from these snakes that need to be targeted will be provided by the venom glands.
They said, “In less than 2-3 years and by testing in trials rapidly, we believe we can produce a synthetic humanized antivenom.”
A researcher with the Indian Institute of Science, Bengaluru, Karthik Sunagar said “With the state-of-the-art sequencing technologies, this is the first genome of Indian snake to be sequenced. Such a high-quality genome will be a great resource for understanding the evolution of this medically important snake and its venom repertoire and it could also be very beneficial for the next-generation recombinant antivenoms’ innovation.”



Comments

Popular posts from this blog

Beer production

Brewing  is the production of  beer  by steeping  a  starch  source (commonly cereal  grains, the most popular of which is  barley ) [1]  in water and  fermenting  the resulting sweet liquid with  yeast . It may be done in a  brewery  by a commercial brewer, at home by a  homebrewer , or by a variety of traditional methods such as communally by the  indigenous peoples in Brazil  when making  cauim . [2]  Brewing has taken place since around the 6th millennium BC, and archaeological evidence suggests that emerging civilizations including  ancient Egypt [3] and  Mesopotamia  brewed beer. [4]  Since the nineteenth century the  brewing industry  has been part of most western economies. The basic ingredients of beer are water and a  fermentable  starch source such as  malted barley . Most beer is fermented with a  brewer's yeast  and flavoured with  hops . [5]  Less widely used starch sources include  millet ,  sorghum and  cassava . [6]  Secondary sources ( adjuncts ), such as

Mechanism of Action of Hydroxychloroquine as an Antirheumatic Drug

Mechanism of Action of Hydroxychloroquine as an Antirheumatic Drug Abstract The antimalarial agents chloroquine and hydroxychloroquine have been used widely for the treatment of rheumatoid arthritis and systemic lupus erythematosus. These compounds lead to improvement of clinical and laboratory parameters, but their slow onset of action distinguishes them from glucocorticoids and nonsteroidal antiinflammatory agents. Chloroquine and hydroxychloroquine increase pH within intracellular vacuoles and alter processes such as protein degradation by acidic hydrolases in the lysosome, assembly of macromolecules in the endosomes, and posttranslation modification of proteins in the Golgi apparatus. It is proposed that the antirheumatic properties of these compounds results from their interference with "antigen processing" in macrophages and other antigen-presenting cells. Acidic cytoplasmic compartments are required for the antigenic protein to be digested and for the pept

HAZARD ANALYSIS AND CRITICAL CONTROL POINT (HACCP) SYSTEM AND GUIDELINES FOR ITS APPLICATION. And All HACCP concept And Conclusion

All Concept of HACCP PREAMBLE The first section of this document sets out the principles of the Hazard Analysis and Critical Control Point (HACCP) system adopted by the Codex Alimentarius Commission. The second section provides general guidance for the application of the system while recognizing that the details of application may vary depending on the circumstances of the food operation The HACCP system, which is science based and systematic, identifies specific hazards and measures for their control to ensure the safety of food. HACCP is a tool to assess hazards and establish control systems that focus on prevention rather than relying mainly on end-product testing. Any HACCP system is capable of accommodating change, such as advances in equipment design, processing procedures or technological developments. HACCP can be applied throughout the food chain from primary production to final consumption and its implementation should be guided by scientific evidence of risks to human health